RIPK3 and neoplasm: Altogether, RIPK3-mediated necroptosis has significant effects on tumor growth, progression, and metastasis, indicating that targeting RIPK3-mediated necroptosis represents an effective strategy for inhibiting tumor development and progression in clinical practice.